Article
Heterozygous disruption of SERCA2a is not associated with impairment of cardiac performance in humans: implications for SERCA2a as a therapeutic target in heart failure.
Heart (British Cardiac Society) - 1 Jan 2006
Mayosi B M, Kardos A, Davies C H, Gumedze F, Hovnanian A, Burge S, Watkins H
Abstract excerpt
OBJECTIVE: To verify whether a deficiency in the cardiac sarcoplasmic reticulum pump SERCA2a causes cardiac dysfunction in humans. DESIGN: Cardiac performance was measured in a serendipitous human model of primary SERCA2a deficiency, Darier's disease, an autosomal dominant skin disorder caused by mutations inactivating one copy of the ATP2A2 gene, which encodes SERCA2a. METHODS: Systolic and diastolic function...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
